Evidence map›Paper›PMID 37443612›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Evaluation of a Sample-to-Result POCKIT Central SARS-CoV-2 PCR System.

Jin-Hui Zhu, Chia-Hsing Tai, Chia-Fong Ping, Pin-Hsing Chou, Yun-Long Tsai, Simon Chung, Laura Bradner, Michael Pentella, Phillip Gauger, Jianqiang Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jin-Hui ZhuDepartment of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.
Chia-Hsing TaiGeneReach Biotechnology Corporation, Taichung 407, Taiwan.
Chia-Fong PingGeneReach Biotechnology Corporation, Taichung 407, Taiwan.
Pin-Hsing ChouGeneReach Biotechnology Corporation, Taichung 407, Taiwan.
Yun-Long TsaiGeneReach Biotechnology Corporation, Taichung 407, Taiwan.
Simon ChungGeneReach Biotechnology Corporation, Taichung 407, Taiwan.
Laura BradnerDepartment of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.
Michael PentellaState Hygienic Laboratory, University of Iowa, Coralville, IA 52241, USA.
Phillip GaugerDepartment of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0003-2540-8769
Jianqiang ZhangDepartment of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA.ORCID 0000-0001-7228-6202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of COVID-19 has caused unprecedented impacts on global public health and many other aspects. Meanwhile, many types of methods have been developed to detect the causative agent, SARS-CoV-2; this has greatly advanced the technologies in the diagnostic field. Here, we describe the development and validation of a sample-in-result-out POCKIT Central SARS-CoV-2 PCR system for detecting SARS-CoV-2 in comparison with a commercial reference real-time RT-PCR assay (TaqPath COVID-19 Combo Kit). Both assays were specific and did not cross-react with non-SARS-CoV-2 agents. Both assays were able to detect various SARS-CoV-2 strains including some variants. Based on testing serial dilutions of SARS-CoV-2 USA-WA1/2020 isolate, the limit of detection was 0.8 TCID

Indexed as

COVID-19PCRPOCKIT Centralpoint-of-careSARS-CoV-2

Identifiers

PMID37443612
PMCPMC10340693

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.